BRKR
Bruker Corporation
NasdaqGSUSDEQUITY
DELAYED
Last price
59.56
▼ 0.36 (0.60%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
59.92
Prev close
59.92
Day high
60.31
Day low
58.06
Volume
3.12M
Market cap
—
P/E (TTM)
—
52W range
28.53 – 65.30
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
+3.22%
+4.6%
1M
-4.17%
-7.9%
3M
+32.41%
+29.3%
6M
+55.59%
+44.5%
YTD
+26.43%
+14.1%
1Y
+76.58%
+56.6%
3Y
-9.35%
-83.5%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $3.44B | $3.37B | $2.96B | $2.53B | +2.1% |
| Operating revenue | $3.44B | $3.37B | $2.96B | $2.53B | +2.1% |
| Cost of revenue | $1.86B | $1.72B | $1.45B | $1.23B | +8.3% |
| Gross profit | $1.58B | $1.65B | $1.51B | $1.31B | -4.4% |
| Research & development | $395.20M | $376.50M | $294.80M | $235.90M | +5.0% |
| Selling, general & admin | $946.50M | $893.80M | $729.40M | $607.40M | +5.9% |
| Total operating expense | $1.34B | $1.27B | $1.02B | $843.30M | +5.6% |
| Operating income | $236.00M | $379.20M | $489.10M | $462.40M | -37.8% |
| Net interest income | -$46.70M | -$38.60M | -$5.20M | -$12.00M | -21.0% |
| Pre-tax income | $22.00M | $206.90M | $544.20M | $413.90M | -89.4% |
| Tax provision | $29.30M | $91.40M | $117.70M | $116.40M | -67.9% |
| Net income | -$8.60M | $113.10M | $427.20M | $296.60M | -107.6% |
| Net income to common | -$22.50M | $113.10M | $427.20M | $296.60M | -119.9% |
| Basic EPS | -0.15 | 0.76 | 2.92 | 2.00 | -119.7% |
| Diluted EPS | -0.15 | 0.76 | 2.90 | 1.99 | -119.7% |
| EBIT | $82.30M | $254.80M | $560.60M | $430.00M | -67.7% |
| EBITDA | $302.60M | $438.60M | $675.50M | $518.70M | -31.0% |
| Basic shares | 151.80M | 149.00M | 146.40M | 148.60M | +1.9% |
| Diluted shares | 151.80M | 149.50M | 147.20M | 149.40M | +1.5% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $298.80M | $183.40M | $488.30M | $645.50M | +62.9% |
| Cash & short-term investments | $298.80M | $183.40M | $488.30M | $645.50M | +62.9% |
| Accounts receivable | $544.90M | $565.50M | $492.00M | $472.70M | -3.6% |
| Inventory | $1.09B | $1.07B | $968.30M | $800.10M | +2.5% |
| Total current assets | $2.21B | $2.05B | $2.16B | $2.11B | +7.8% |
| Property, plant & equipment | $910.60M | $814.80M | $691.40M | $538.20M | +11.8% |
| Goodwill & intangibles | $2.45B | $2.42B | $913.10M | $728.50M | +1.1% |
| Total assets | $6.24B | $5.81B | $4.25B | $3.61B | +7.5% |
| Total current liabilities | $1.28B | $1.28B | $1.20B | $914.30M | -0.2% |
| Current debt | $16.60M | $32.50M | $121.20M | $18.70M | -48.9% |
| Long-term debt | $1.85B | $2.06B | $1.16B | $1.20B | -10.2% |
| Total debt | $2.04B | $2.25B | $1.38B | $1.27B | -9.0% |
| Total liabilities | $3.73B | $3.99B | $2.84B | $2.48B | -6.5% |
| Retained earnings | $2.36B | $2.41B | $2.32B | $1.93B | -1.9% |
| Working capital | $933.30M | $771.90M | $962.10M | $1.20B | +20.9% |
| Net tangible assets | $9.20M | -$638.60M | $464.10M | $385.30M | +101.4% |
| Shares issued | 152.14M | 182.46M | 175.94M | 175.39M | -16.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$8.30M | $113.80M | $428.50M | $298.50M | -107.3% |
| Depreciation & amortisation | $220.30M | $183.80M | $114.90M | $88.70M | +19.9% |
| Stock-based compensation | $20.20M | $25.30M | $30.90M | $27.70M | -20.2% |
| Change in working capital | -$144.80M | -$118.80M | -$87.80M | -$144.10M | -21.9% |
| Operating cash flow | $134.10M | $251.30M | $350.10M | $274.40M | -46.6% |
| Capital expenditure | -$120.20M | -$115.30M | -$106.90M | -$129.20M | -4.2% |
| Investing cash flow | -$196.50M | -$1.76B | -$326.00M | -$251.60M | +88.8% |
| Share buybacks | -$10.00M | $0 | -$152.30M | -$263.10M | — |
| Dividends paid | -$32.90M | -$30.20M | -$29.40M | -$29.80M | -8.9% |
| Financing cash flow | $135.10M | $1.23B | -$193.40M | -$415.30M | -89.0% |
| Free cash flow | $13.90M | $136.00M | $243.20M | $145.20M | -89.8% |
| End cash position | $303.10M | $186.70M | $491.60M | $648.70M | +62.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $838.50M | $823.40M | $977.20M | $860.50M | $797.40M | +1.8% |
| Operating revenue | $838.50M | $823.40M | $977.20M | $860.50M | $797.40M | +1.8% |
| Cost of revenue | $422.50M | $443.60M | $528.00M | $481.10M | $439.50M | -4.8% |
| Gross profit | $416.00M | $379.80M | $449.20M | $379.40M | $357.90M | +9.5% |
| Research & development | $94.30M | $101.30M | $99.60M | $98.30M | $100.20M | -6.9% |
| Selling, general & admin | $238.90M | $242.10M | $247.20M | $242.50M | $231.40M | -1.3% |
| Total operating expense | $333.20M | $343.40M | $337.40M | $344.40M | $331.60M | -3.0% |
| Operating income | $82.80M | $36.40M | $111.80M | $35.00M | $26.30M | +127.5% |
| Net interest income | -$2.50M | -$4.30M | -$12.30M | -$12.50M | -$12.80M | +41.9% |
| Pre-tax income | -$40.70M | $21.90M | $68.20M | -$71.80M | $500.00K | -285.8% |
| Tax provision | $14.20M | $2.50M | $37.80M | -$14.10M | -$3.10M | +468.0% |
| Net income | -$52.00M | $14.40M | $26.00M | -$59.60M | $7.60M | -461.1% |
| Net income to common | -$62.90M | $3.50M | $14.90M | -$62.40M | $7.60M | -1,897.1% |
| Basic EPS | -0.41 | 0.02 | 0.10 | -0.41 | 0.05 | -2,150.0% |
| Diluted EPS | -0.41 | 0.02 | 0.10 | -0.41 | 0.05 | -2,150.0% |
| EBIT | -$22.90M | $34.10M | $79.40M | -$51.50M | $16.20M | -167.2% |
| EBITDA | $35.10M | $92.40M | $137.50M | $4.20M | $72.30M | -62.0% |
| Basic shares | 152.30M | 152.20M | 152.00M | 151.80M | 151.60M | +0.1% |
| Diluted shares | 152.30M | 152.70M | 152.50M | 151.80M | 151.70M | -0.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $184.90M | $133.40M | $298.80M | $293.10M | $92.00M | +38.6% |
| Cash & short-term investments | $222.50M | $133.40M | $298.80M | $293.10M | $92.00M | +66.8% |
| Accounts receivable | $545.90M | $542.70M | $544.90M | $550.90M | $522.60M | +0.6% |
| Inventory | $1.12B | $1.12B | $1.09B | $1.20B | $1.22B | -0.1% |
| Total current assets | $2.23B | $2.10B | $2.21B | $2.35B | $2.16B | +5.8% |
| Property, plant & equipment | $714.10M | $719.60M | $910.60M | $746.70M | $758.50M | -0.8% |
| Goodwill & intangibles | $2.30B | $2.48B | $2.45B | $2.47B | $2.62B | -7.2% |
| Total assets | $6.05B | $6.13B | $6.24B | $6.43B | $6.34B | -1.3% |
| Total current liabilities | $1.20B | $1.36B | $1.28B | $1.27B | $1.35B | -11.1% |
| Current debt | $10.10M | $8.40M | $16.60M | $24.30M | $55.70M | +20.2% |
| Long-term debt | $1.81B | $1.66B | $1.85B | $1.98B | $2.38B | +9.1% |
| Total debt | $1.82B | $1.67B | $2.04B | $2.01B | $2.44B | +9.2% |
| Total liabilities | $3.62B | $3.63B | $3.73B | $3.94B | $4.47B | -0.3% |
| Retained earnings | $2.29B | $2.36B | $2.36B | $2.35B | $2.42B | -3.0% |
| Shareholder equity | $2.38B | $2.45B | $2.46B | $2.43B | $1.80B | -2.8% |
| Working capital | $1.02B | $748.50M | $933.30M | $1.08B | $815.30M | +36.3% |
| Net tangible assets | $83.80M | -$26.20M | $9.20M | -$36.90M | -$814.80M | +419.8% |
| Shares issued | 152.35M | 152.22M | 152.14M | 182.92M | 182.70M | +0.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | -$50.90M | $15.70M | $29.20M | -$58.50M | $4.20M | — | -424.2% |
| Depreciation & amortisation | $58.00M | $58.30M | $58.10M | $55.70M | $56.10M | — | -0.5% |
| Stock-based compensation | — | — | — | — | — | — | — |
| Change in working capital | -$196.90M | -$24.20M | $124.20M | -$118.00M | -$160.30M | — | -713.6% |
| Operating cash flow | -$77.40M | $71.20M | $229.80M | -$33.20M | -$127.50M | — | -208.7% |
| Capital expenditure | -$28.80M | -$24.20M | -$52.00M | -$20.90M | -$21.30M | — | -19.0% |
| Investing cash flow | -$25.30M | -$39.70M | -$55.50M | -$23.80M | -$91.10M | — | +36.3% |
| Share buybacks | — | $0 | $0 | $0 | $0 | -$10.00M | — |
| Dividends paid | -$18.50M | -$18.60M | -$17.60M | $0 | -$7.60M | — | +0.5% |
| Financing cash flow | $149.20M | -$204.90M | -$167.60M | $258.40M | $95.50M | — | +172.8% |
| Free cash flow | -$106.20M | $47.00M | $177.80M | -$54.10M | -$148.80M | — | -326.0% |
| End cash position | $189.10M | $137.60M | $303.10M | $297.30M | $96.20M | — | +37.4% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
58.09
+2.53% from price
SMA 20
58.23
+2.29% from price
SMA 50
58.47
+1.86% from price
SMA 100
51.08
+16.60% from price
SMA 200
47.18
+26.23% from price
EMA 12
58.19
+2.36% from price
EMA 26
58.10
+2.52% from price
EMA 50
56.80
+4.86% from price
RSI (14)
53.4
Neutral
MACD (12,26,9)
0.09
Hist 0.26
ATR (14)
3.48
5.84% of price
Realised vol 30D
85.4%
Annualised
Bollinger upper
66.16
20, 2σ
Bollinger lower
50.30
20, 2σ
50 / 200 cross
Golden
58.47 vs 47.18
Trend bias
Above 200
+26.23%
Risk profile
Beta vs SPY
1.29
More volatile than market
Correlation to SPY
0.29
Largely independent
Realised vol 30D
85.4%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-39.8%
Peak to trough
Max drawdown 5Y
-68.9%
Peak to trough
ATR 14
3.48
5.84% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
3 Unpopular Stocks with Questionable Fundamentals
StockStory · 2d ago
The 5 Most Interesting Analyst Questions From Bruker’s Q2 Earnings Call
StockStory · 10d ago
Bruker (BRKR) Q2 2026 Earnings Call Transcript
Motley Fool · 11d ago
Bruker Expands Atinary Collaboration, Makes Minority Investment in AI R&D Firm
MT Newswires · 12d ago
Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories
Business Wire · 12d ago
Bruker Acquires Majority Stake in Mimetas to Expand Disease Biology Research
MT Newswires · 12d ago
Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development
Business Wire · 13d ago
Is Bruker (BRKR) Fairly Valued After Its 52 Week High?
Simply Wall St. · 17d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.